Phagocytosis of collagen by fibroblasts and invasive cancer cells is mediated by MT1-MMP
- PMID: 17635128
- DOI: 10.1042/BST0350704
Phagocytosis of collagen by fibroblasts and invasive cancer cells is mediated by MT1-MMP
Abstract
Degradation of collagen is required for the physiological remodelling of connective tissues during growth and development, as well as in wound healing, inflammatory diseases, and cancer cell invasion. In remodelling adult tissues, degradation of collagen occurs primarily through a phagocytic pathway. While various steps in this pathway have been characterized, the enzyme required to fragment collagen fibrils for phagocytosis has not been identified. Laser confocal microscopy, transmission electron microscopy and biochemical assays were used to show that degradation of collagen substrates by fibroblasts correlated with the expression of the membrane-bound metalloproteinase MT1-MMP (membrane-type 1 matrix metalloproteinase). The MT1-MMP was localized to sites of collagen cleavage on the cell surface and also within the cells. In contrast with MT1-MMP, the gelatinase MMP-2 was not required for collagen phagocytosis. Similar analyses of several ovarian cancer, breast cancer and fibrosarcoma cells indicated that highly metastatic cells also degrade collagen through a phagocytic pathway that is mediated by MT1-MMP. Collectively, these studies demonstrate a pivotal role for catalytically active MT1-MMP in preparing collagen fibrils for phagocytic degradation by normal and transformed cells.
Similar articles
-
A critical role for the membrane-type 1 matrix metalloproteinase in collagen phagocytosis.Mol Biol Cell. 2006 Nov;17(11):4812-26. doi: 10.1091/mbc.e06-06-0486. Epub 2006 Sep 13. Mol Biol Cell. 2006. PMID: 16971509 Free PMC article.
-
MT1-MMP is required for efficient tumor dissemination in experimental metastatic disease.Oncogene. 2008 May 22;27(23):3274-81. doi: 10.1038/sj.onc.1210982. Epub 2007 Dec 10. Oncogene. 2008. PMID: 18071307
-
Stroma-derived matrix metalloproteinase (MMP)-2 promotes membrane type 1-MMP-dependent tumor growth in mice.Cancer Res. 2007 May 1;67(9):4311-9. doi: 10.1158/0008-5472.CAN-06-4761. Cancer Res. 2007. PMID: 17483344
-
Matrix invasion by tumour cells: a focus on MT1-MMP trafficking to invadopodia.J Cell Sci. 2009 Sep 1;122(Pt 17):3015-24. doi: 10.1242/jcs.034561. J Cell Sci. 2009. PMID: 19692588 Review.
-
Tube travel: the role of proteases in individual and collective cancer cell invasion.Cancer Res. 2008 Sep 15;68(18):7247-9. doi: 10.1158/0008-5472.CAN-08-0784. Cancer Res. 2008. PMID: 18794108 Review.
Cited by
-
Cancer as a metabolic disease.Nutr Metab (Lond). 2010 Jan 27;7:7. doi: 10.1186/1743-7075-7-7. Nutr Metab (Lond). 2010. PMID: 20181022 Free PMC article.
-
Matrix metalloproteinase collagenolysis in health and disease.Biochim Biophys Acta Mol Cell Res. 2017 Nov;1864(11 Pt A):1940-1951. doi: 10.1016/j.bbamcr.2017.04.015. Epub 2017 Apr 26. Biochim Biophys Acta Mol Cell Res. 2017. PMID: 28456643 Free PMC article. Review.
-
Membrane type 1 matrix metalloproteinase-mediated stromal syndecan-1 shedding stimulates breast carcinoma cell proliferation.Cancer Res. 2008 Nov 15;68(22):9558-65. doi: 10.1158/0008-5472.CAN-08-1645. Cancer Res. 2008. PMID: 19010933 Free PMC article.
-
Automatic generation of boundary conditions using demons nonrigid image registration for use in 3-D modality-independent elastography.IEEE Trans Biomed Eng. 2011 Sep;58(9):2607-16. doi: 10.1109/TBME.2011.2159791. Epub 2011 Jun 16. IEEE Trans Biomed Eng. 2011. PMID: 21690002 Free PMC article.
-
The Expanding Role of MT1-MMP in Cancer Progression.Pharmaceuticals (Basel). 2019 May 20;12(2):77. doi: 10.3390/ph12020077. Pharmaceuticals (Basel). 2019. PMID: 31137480 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous